SKI Market

A+| A| A-|

Indian Indices

Sensex

74,068.45 1,372.06
( 1.89%)

Global Indices

Nasdaq

46,234.46 635.98
(1.39%)

Dow Jones

6,603.33 75.85
(1.16%)

Hang Seng

52,101.04 585.55
(1.14%)

Nikkei 225

9,923.24 4.91
(0.05%)

Forex

USD-INR

93.49 0.36
(0.39%)

EUR-INR

108.15 0.98
(0.91%)

GBP-INR

124.68 0.54
(0.44%)

JPY-INR

0.59 0.00
(0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78690

INE0MRE01011

67.8370031

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFINIUM

37.38

316.34

EPS(TTM)

Face Value()

Div & Yield %

5.43

Back

acutaas chemicals ltd

NCL Research and Financial Services standalone net profit declines 10.09% in the September 2025 quarter

Nov 14,2025

Net profit of NCL Research and Financial Services declined 10.09% to Rs 0.98 crore in the quarter ended September 2025 as against Rs 1.09 crore during the previous quarter ended September 2024. Sales rose 30.41% to Rs 1.93 crore in the quarter ended September 2025 as against Rs 1.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.93	1.48	30
OPM %	81.35	29.73	-
PBDT	1.32	1.50	-12
PBT	1.31	1.49	-12
NP	0.98	1.09	-10

74,068.45 1,372.06 ( 1.89%)

46,234.46 635.98 (1.39%)

6,603.33 75.85 (1.16%)

52,101.04 585.55 (1.14%)

9,923.24 4.91 (0.05%)

93.49 0.36 (0.39%)

108.15 0.98 (0.91%)

124.68 0.54 (0.44%)

0.59 0.00 (0.10%)